肺炎支原体相关皮肤黏膜疾病的研究进展

doi:10.35541/cjd.20230769

Abstract

Abstract: 【Abstract】 Mycoplasma pneumoniae （MP） infection may cause multisystem damage, among which skin and mucosal diseases are one of the most common extrapulmonary manifestations. In addition to common clinical manifestations such as urticaria and anaphylactoid purpura, there have been increasing cases of Mycoplasma pneumoniae-induced erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and Mycoplasma pneumoniae-induced rash and mucositis reported in China and other countries. These diseases can lead to rare and severe skin and mucosal adverse reactions. This review summarizes Mycoplasma pneumoniae-associated skin and mucosal diseases, in order to enhance clinicians' understanding of these diseases and provide help for the treatment.

Key words: Pneumonia, Mycoplasma, Erythema multiforme, Setevens-Johnson syndrome, Toxic epidermal necrolysis, Mycoplasma pneumoniae-induced rash and mucositis

Ma lan, Cao Shihe, Fu Jiayao, Li Nan, Wang Xiaohong. Advances in Mycoplasma pneumoniae-associated skin and mucosal diseases[J]. Chinese Journal of Dermatology,2024,e20230769. doi:10.35541/cjd.20230769

References ［38］

［1］	Rodman Berlot J, Mrvič T, Košnik M, et al. The association between Mycoplasma pneumoniae genotype and cutaneous disease［J］. Microorganisms, 2023,11（1）:205. doi: 10.3390/microorganisms11010205.
［2］	贾艳红, 郭芳, 武晓圆, 等. 儿童肺炎支原体诱导的皮疹和黏膜炎临床特征分析［J］. 首都医科大学学报, 2023,44（1）:131⁃136. doi: 10.3969/j.issn.1006⁃7795.2023.01.019.
［3］	Hu J, Ye Y, Chen X, et al. Insight into the pathogenic mechanism of Mycoplasma pneumoniae［J］. Curr Microbiol, 2022,80（1）:14. doi: 10.1007/s00284⁃022⁃03103⁃0.
［4］	Poddighe D. Extra⁃pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis［J］. Curr Opin Rheumatol, 2018,30（4）:380⁃387. doi: 10.1097/BOR.0000000000000494.
［5］	Ramien ML. Reactive infectious mucocutaneous eruption: Mycoplasma pneumoniae⁃induced rash and mucositis and other parainfectious eruptions［J］. Clin Exp Dermatol, 2021,46（3）:420⁃429. doi: 10.1111/ced.14404.
［6］	Chen N, Li M. Case report and literature review: clinical characteristics of 10 children with Mycoplasma pneumoniae⁃induced rash and mucositis［J］. Front Pediatr, 2022,10:823376. doi: 10.3389/fped.2022.823376.
［7］	Betti C, Camozzi P, Gennaro V, et al. Atypical bacterial pathogens and small⁃vessel leukocytoclastic vasculitis of the skin in children: systematic literature review［J］. Pathogens, 2021,10（1）:31. doi: 10.3390/pathogens10010031.
［8］	Lai LJ, Chen VC, Yang YH, et al. Mycoplasma infection and ocular surface diseases: a nationwide cohort study［J］. Sci Rep, 2021,11（1）:22680. doi: 10.1038/s41598⁃021⁃01941⁃9.
［9］	刘洋, 刘瀚旻. 肺炎支原体感染与血管炎［J］. 中华实用儿科临床杂志, 2021,36（16）:1218⁃1221. doi: 10.3760/cma.j.cn 101070⁃20210727⁃00890.
［10］	Liu C, Luo L, Fu M, et al. Analysis of children with Henoch⁃Schonlein purpura secondary to infection［J］. Clin Rheumatol, 2022,41（3）:803⁃810. doi: 10.1007/s10067⁃021⁃06007⁃9.
［11］	Grünwald P, Mockenhaupt M, Panzer R, et al. Erythema multiforme, Stevens⁃Johnson syndrome/toxic epidermal necrolysis ⁃ diagnosis and treatment［J］. J Dtsch Dermatol Ges, 2020,18（6）:547⁃553. doi: 10.1111/ddg.14118.
［12］	Canavan TN, Mathes EF, Frieden I, et al. Mycoplasma pneumoniae⁃induced rash and mucositis as a syndrome distinct from Stevens⁃Johnson syndrome and erythema multiforme: a systematic review［J］. J Am Acad Dermatol, 2015,72（2）:239⁃245. doi: 10.1016/j.jaad.2014.06.026.
［13］	Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria［J］. Allergy, 2022,77（3）:734⁃766. doi: 10.1111/all. 15090.
［14］	Konstantinou GN, Sagonas I, Giannoula FC. Chronic spontaneous and inducible urticaria associated with Mycoplasma pneumoniae infection［J］. Cureus, 2021,13（10）:e18746. doi: 10.7759/cureus. 18746.
［15］	Yong SB, Yeh WC, Wu HJ, et al. Impact of Mycoplasma pneumonia infection on urticaria: a nationwide, population⁃based retrospective cohort study in Taiwan［J］. PLoS One, 2019,14（12）:e0226759. doi: 10.1371/journal.pone.0226759.
［16］	De Luigi G, Meoli M, Zgraggen L, et al. Mucosal respiratory syndrome: a systematic literature review［J］. Dermatology, 2022,238（1）:53⁃59. doi: 10.1159/000514815.
［17］	魏二虎, 方敩, 靳培娜, 等. 儿童肺炎支原体感染致多形红斑3例［J］. 中华实用儿科临床杂志, 2020,35（20）:1583⁃1585. doi: 10.3760/cma.j.cn101070⁃20190708⁃00615.
［18］	Amode R, Ingen⁃Housz⁃Oro S, Ortonne N, et al. Clinical and histologic features of Mycoplasma pneumoniae⁃related erythema multiforme: a single⁃center series of 33 cases compared with 100 cases induced by other causes［J］. J Am Acad Dermatol, 2018,79（1）:110⁃117. doi: 10.1016/j.jaad.2018.03.013.
［19］	Zoghaib S, Kechichian E, Souaid K, et al. Triggers, clinical manifestations, and management of pediatric erythema multiforme: a systematic review［J］. J Am Acad Dermatol, 2019,81（3）:813⁃822. doi: 10.1016/j.jaad.2019.02.057.
［20］	Ben Rejeb M, Ben Hammouda M, Korbi M, et al. Mycoplasma pneumoniae⁃induced rash and mucositis: a new entity［J］. Indian J Dermatol Venereol Leprol, 2022,88（3）:349⁃353. doi: 10. 25259/IJDVL_660_19.
［21］	中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识［J］. 中华皮肤科杂志, 2021,54（5）:376⁃381. doi: 10.35541/cjd.20201177.
［22］	Duong TA, Valeyrie⁃Allanore L, Wolkenstein P, et al. Severe cutaneous adverse reactions to drugs［J］. Lancet, 2017,390（10106）:1996⁃2011. doi: 10.1016/S0140⁃6736（16）30378⁃6.
［23］	Lerch M, Mainetti C, Terziroli Beretta⁃Piccoli B, et al. Current perspectives on Stevens⁃Johnson syndrome and toxic epidermal necrolysis［J］. Clin Rev Allergy Immunol, 2018,54（1）:147⁃176. doi: 10.1007/s12016⁃017⁃8654⁃z.
［24］	Liew Y, Choo K, Oh CC, et al. Mycoplasma⁃induced Stevens⁃Johnson syndrome/toxic epidermal necrolysis: case⁃control analysis of a cohort managed in a specialized center［J］. J Am Acad Dermatol, 2022,86（4）:811⁃817. doi: 10.1016/j.jaad.2021. 04.066.
［25］	Giraud⁃Kerleroux L, Bellon N, Welfringer⁃Morin A, et al. Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients［J］. J Eur Acad Dermatol Venereol, 2021,35（10）:2051⁃2058. doi: 10.1111/jdv. 17469.
［26］	Liccioli G, Filippeschi C, Giovannini M, et al. Mycoplasma pneumoniae⁃associated mucocutaneous disease in children: a case series with allergy workup in a tertiary care paediatric hospital［J］. Clin Exp Allergy, 2021,51（5）:740⁃744. doi: 10. 1111/cea.13861.
［27］	Katsumi T, Hama N, Iwai Y, et al. Mycoplasma pneumoniae⁃associated Stevens⁃Johnson syndrome: characteristic histological features of mucosal lesion［J］. J Eur Acad Dermatol Venereol, 2021,35（1）:e56⁃e57. doi: 10.1111/jdv.16796.
［28］	Haseeb A, Elhusseiny AM, ElSheikh RH, et al. Ocular involvement in Mycoplasma induced rash and mucositis: a systematic review of the literature［J］. Ocul Surf, 2023,28:1⁃10. doi: 10.1016/j.jtos.2022.11.007.
［29］	Mazori DR, Nagarajan S, Glick SA. Recurrent reactive infectious mucocutaneous eruption （RIME）: insights from a child with three episodes［J］. Pediatr Dermatol, 2020,37（3）:545⁃547. doi: 10.1111/pde.14142.
［30］	赵德育, 邓欢. 肺炎支原体肺炎实验室诊断的意义及进展［J］. 中华实用儿科临床杂志, 2021,36（16）:1205⁃1209. doi: 10.3760/cma.j.cn101070⁃20210726⁃00884.
［31］	中华人民共和国国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南（2023年版）［J］. 中国合理用药探索, 2023,20（3）:16⁃24. doi: 10.3969/j.issn.2096⁃3327.2023.03.003.
［32］	Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae among children hospitalized with community⁃acquired pneumonia［J］. Clin Infect Dis, 2019,68（1）:5⁃12. doi: 10.1093/cid/ciy419.
［33］	Hahn DW, Atkinson CE, Le M. Multiple anatomic sites of infarction in a pediatric patient with M. pneumoniae infection, a case report［J］. BMC Pediatr, 2021,21（1）:372. doi: 10.1186/s12887⁃021⁃02845⁃3.
［34］	Burns EK, Lin D. Mycoplasma pneumoniae⁃induced rash and mucositis in a young adult［J］. Am J Med, 2021,134（2）:213⁃215. doi: 10.1016/j.amjmed.2020.09.012.
［35］	Gise R, Elhusseiny AM, Scelfo C, et al. Mycoplasma pneumoniae⁃induced rash and mucositis: a longitudinal perspective and proposed management criteria［J］. Am J Ophthalmol, 2020,219:351⁃356. doi: 10.1016/j.ajo.2020.06.010.
［36］	Jin HD, Siatkowski RM, Siatkowski RL. Ocular manifestations of Mycoplasma⁃induced rash and mucositis［J］. J AAPOS, 2020,24（4）:249⁃251. doi: 10.1016/j.jaapos.2020.04.006.
［37］	Shanbhag SS, Rashad R, Chodosh J, et al. Long⁃term effect of a treatment protocol for acute ocular involvement in Stevens⁃Johnson syndrome/toxic epidermal necrolysis［J］. Am J Ophthalmol, 2019,208:331⁃341. doi: 10.1016/j.ajo.2019.07.006.
［38］	Heymann WR. More than Mycoplasma⁃induced rash and mucositis: the potential role of Mycoplasma pneumoniae in Stevens⁃Johnson syndrome/toxic epidermal necrolysis［J］. J Am Acad Dermatol, 2022,86（4）:746⁃747. doi: 10.1016/j.jaad.2021. 12.037.

[1]	Deng Wei, Jiang Lixiao, Su Wei, Yang Zhou, Liu Xiaoyan, Zhang Gaolei. Clinical analysis of 15 cases of Mycoplasma pneumoniae-induced rash and mucositis [J]. Chinese Journal of Dermatology, 2025, 58(5): 460-463.
[2]	Bao Shijie, Han Mei, Zhou Xiaoyong. Analysis of factors influencing the efficacy of etanercept in the treatment of toxic epidermal necrolysis based on literature review [J]. Chinese Journal of Dermatology, 2025, 58(4): 352-355.
[3]	Jing Danrui, Chen Hao, Feng Suying, Li Xiaofang, Wang Xiaopo. A case of cutaneous chronic active Epstein-Barr virus disease manifesting as persistent erythema multiforme [J]. Chinese Journal of Dermatology, 2024, 57(9): 815-820.
[4]	Deng Wei, Zhang Gaolei, Chen Jianyou, Zhang Sheng, Jiang Lixiao, Liu Xiaoyan, Su Wei. Skin manifestations of 61 children with coronavirus disease 19 [J]. Chinese Journal of Dermatology, 2023, 56(12): 1154-1157.
[5]	Dildar·Yasen, Mei Xingxing, Zhou Hui, Chen Xiaohong, Tang Xuhua. Clinical features and prognosis of eight cases of Mycoplasma pneumoniae-induced rash and mucositis [J]. Chinese Journal of Dermatology, 2022, 55(9): 767-771.
[6]	Wang Qian, Qi Bo, Zhang Lixia, Liu Wei, Lan Yunping. Comparison of the performance of SCORTEN and ABCD-10 in evaluating the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(7): 566-570.
[7]	Qu Litian, Fang Yihong, Su Huichun, Cheng Bo. A case of toxic epidermal necrolysis complicated by hemophagocytic syndrome [J]. Chinese Journal of Dermatology, 2020, 53(9): 732-734.
[8]	. A case of systemic lupus erythematosus complicated by toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2017, 50(9): 683-683.
[9]	. A case of toxic epidermal necrolysis treated with a tumor necrosis factor-alpha antagonist [J]. Chinese Journal of Dermatology, 2012, 45(5): 368-368.
[10]	. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study of 61 cases [J]. Chinese Journal of Dermatology, 2008, 41(8): 542-545.
[11]	JIANG Haiyan, SONG Fangji, ZHAI Ning. Study on the Association Between HLA and Erythema Multiforme [J]. Chinese Journal of Dermatology, 2000, 33(5): 336-337.
[12]	Qu Bingxin, Chen Ping, Jin Peiying. Detection of Herpes Simplex Virus DNA in Cutaneous Lesions of Erythema Multiformeby Polymerase Chain Reaction [J]. Chinese Journal of Dermatology, 1996, 29(4): 234-236.

Advances in Mycoplasma pneumoniae-associated skin and mucosal diseases

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［38］

Related Articles 12

Metrics

Comments

Recommended 10